In the current study, we revealed that the PCs can also control the activity of MMP-2 by acting on the expression levels of MMP-2 inhibitors TIMP-1 and TIMP-2 (Fig. 5) and the levels of uPAR and PAI-1 in tumor cells (Fig. 6). The gene discussed is MMP2; the disease is neoplasm.